> 課題検索詳細
前に戻る
検索画面に戻る
研究課題情報
（単位：千円）
研究成果情報
1.Kajikawa S, Matsuhashi M, Kobayashi K, Hitomi T, Daifu-Kobayashi M, Kobayashi T, Yamao Y, Kikuchi T, Yoshida K, Kunieda T, Matsumoto R, Kakita A, Namiki T, Tsuda I, Miyamoto S, Takahashi R, Ikeda A. Two types of clinical ictal direct current shifts in invasive EEG of intractable focal epilepsy identified by waveform cluster analysis. Clin Neurophysiol. 2022, Mar 9, 137: 113-121, doi:10.1016/j.clinph.2022.02.021.
2.Ueda Y, Fujishige S, Goto T, Kimura S, Namatame N, Narugami M, Nakakubo S, Nakajima M, Egawa K, Kaneko N, Nakayama K, Hishimura N, Yamaguchi T, Nakamura A, Shiraishi H. Adrenal function during long-term ACTH therapy for patients with developmental and epileptic encephalopathy. Epilepsia Open. 2022, Mar, 7(1): 194-200, doi:10.1002/epi4.12566.
3.Miyake N, Silva S, Troncoso M, Okamoto N, Andachi Y, Kato M, Iwabuchi C, Hirose M, Fujita A, Uchiyama Y, Matsumoto N. A homozygous ABHD16A variant causes a complex hereditary spastic paraplegia with developmental delay, absent speech, and characteristic face. Clin Genet. 2022, Mar, 101(3): 359-363, doi:10.1111/cge.14097.
4.Takahashi Y, Ota A, Tohyama J, Kirino T, Fujiwara Y, Ikeda C, Tanaka S, Takahashi J, Shinoki T, Shiraga H, Inoue T, Fujita H, Bonno M, Nagao M, Kaneko H. Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures. Epilepsia Open. 2022, Mar, 7(1): 85-97, doi:10.1002/epi4.12560.
5.Takei N, Yokomaku D, Yamada T, Nagano T, Kakita A, Namba H, Ushiki T, Takahashi H, Nawa H. EGF Downregulates Presynaptic Maturation and Suppresses Synapse Formation In Vitro and In Vivo. Neurochem Res. 2022, Jan 4, 10.1007/s11064-021-03524-6: doi:10.1007/s11064-021-03524-6.
6.Hoshino H, Miya F, Kato M, Kanemura H. Efficacy of ethosuximide on atonic seizures with KCNB1 mutation. Pediatr Int. 2022, Jan, 64(1): e14871, doi:10.1111/ped.14871.
7.Okanishi T, Fujii Y, Sakuma S, Shiraishi H, Motoi H, Yazaki K, Enoki H, Fujimoto A. Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes. Brain Dev. 2022, Feb 28, 10.1016/j.braindev.2022.02.005: doi:10.1016/j.braindev.2022.02.005.
8.Fukuoka M, Kuki I, Hattori Y, Tsuji H, Horino A, Nukui M, Inoue T, Okazaki S, Kawawaki H, Kunihiro N, Uda T, Inoue T, Takahashi Y. A case of focal cortical dysplasia type IIa with pathologically suspected bilateral Rasmussen syndrome. Brain Dev. 2022, Feb 28, 10.1016/j.braindev.2022.02.003: doi:10.1016/j.braindev.2022.02.003.
9.Yamamoto Y, Inoue Y, Usui N, Imai K, Kagawa Y, Takahashi Y. Therapeutic drug monitoring for rufinamide in Japanese patients with epilepsy: Focus on drug interactions, tolerability, and clinical effectiveness. Ther Drug Monit. 2022, Feb 21, 10.1097/FTD.0000000000000977: doi:10.1097/FTD.0000000000000977.
10.Inoue Y, Hamano SI, Hayashi M, Sakuma H, Hirose S, Ishii A, Honda R, Ikeda A, Imai K, Jin K, Kada A, Kakita A, Kato M, Kawai K, Kawakami T, Kobayashi K, Matsuishi T, Matsuo T, Nabatame S, Okamoto N, Ito S, Okumura A, Saito A, Shiraishi H, Shirozu H, Saito T, Sugano H, Takahashi Y, Yamamoto H, Fukuyama T, Kuki I. Burden of seizures and comorbidities in patients with epilepsy: a survey based on the tertiary hospital-based Epilepsy Syndrome Registry in Japan. Epileptic Disord. 2022, Feb 1, 24(1): 82-94, doi:10.1684/epd.2021.1361.
11.Inoue Y, Sumitomo K, Matsutani K, Ishii M. Evaluation of real-world effectiveness of perampanel in Japanese adults and older adults with epilepsy. Epileptic Disord. 2022, Feb 1, 24(1): 123-132, doi:10.1684/epd.2021.1369.
12.Kato M, Kada A, Shiraishi H, Tohyama J, Nakagawa E, Takahashi Y, Akiyama T, Kakita A, Miyake N, Fujita A, Saito AM, Inoue Y. Sirolimus for epileptic seizures associated with focal cortical dysplasia type II. Ann Clin Transl Neurol. 2022, Feb, 9(2): 181-192, doi:10.1002/acn3.51505.
13.Hamanaka K, Miyoshi K, Sun JH, Hamada K, Komatsubara T, Saida K, Tsuchida N, Uchiyama Y, Fujita A, Mizuguchi T, Gerard B, Bayat A, Rinaldi B, Kato M, Tohyama J, Ogata K, Shi YS, Saito K, Miyatake S, Matsumoto N. Amelioration of a neurodevelopmental disorder by carbamazepine in a case having a gain-of-function GRIA3 variant. Hum Genet. 2022, Feb, 141(2): 283-293, doi:10.1007/s00439-021-02416-7.
14.Okamoto N, Miya F, Tsunoda T, Kanemura Y, Saitoh S, Kato M, Yanagi K, Kaname T, Kosaki K. Four pedigrees with aminoacyl-tRNA synthetase abnormalities. Neurol Sci. 2022, Apr, 43(4): 2765-2774, doi:10.1007/s10072-021-05626-z.
15.Thamcharoenvipas T, Takahashi Y, Kimura N, Matsuda K, Usui N. Localizing and Lateralizing Value of Seizure Onset Pattern on Surface EEG in FCD Type II. Pediatr Neurol. 2022, Apr, 129: 48-54, doi:10.1016/j.pediatrneurol.2022.01.008.
16.Chiba E, Kimura Y, Shimizu-Motohashi Y, Miyagawa N, Ota M, Shigemoto Y, Ohnishi M, Nakaya M, Nakagawa E, Sasaki M, Sato N. Clinical and neuroimaging findings in patients with lissencephaly/subcortical band heterotopia spectrum: a magnetic resonance conventional and diffusion tensor study. Neuroradiology. 2022, Apr, 64(4): 825-836, doi:10.1007/s00234-021-02836-2.
17.Kuseyri Hubschmann O, Horvath G, Cortes-Saladelafont E, Yildiz Y, Mastrangelo M, Pons R, Friedman J, Mercimek-Andrews S, Wong SN, Pearson TS, Zafeiriou DI, Kulhanek J, Kurian MA, Lopez-Laso E, Oppeboen M, Kilavuz S, Wassenberg T, Goez H, Scholl-Burgi S, Porta F, Honzik T, Santer R, Burlina A, Sivri HS, Leuzzi V, Hoffmann GF, Jeltsch K, Hubschmann D, Garbade SF, i NTD Registry Study Group, Garcia-Cazorla A, Opladen T. (Kato M as a member of iNTD Registry Study Group) Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines. Nat Commun. 2021, Sep 20, 12(1): 5529, doi:10.1038/s41467-021-25515-5.
18.Ueda R, Kaga Y, Kita Y, Nakagawa E, Okada T, Inagaki M. Clinical profile of reading ability and reading and writing achievement of children with borderline full-scale intellectual quotient: a prospective study. BMC Pediatr. 2021, Sep 7, 21(1): 389, doi:10.1186/s12887-021-02865-z.
19.Mizuguchi T, Toyota T, Miyatake S, Mitsuhashi S, Doi H, Kudo Y, Kishida H, Hayashi N, Tsuburaya RS, Kinoshita M, Fukuyama T, Fukuda H, Koshimizu E, Tsuchida N, Uchiyama Y, Fujita A, Takata A, Miyake N, Kato M, Tanaka F, Adachi H, Matsumoto N. Erratum to: Complete sequencing of expanded SAMD12 repeats by long-read sequencing and Cas9-mediated enrichment. Brain. 2021, Sep 4, 144(8): e67, doi:10.1093/brain/awab183.
20.Matsumoto A, Kojima K, Miya F, Miyauchi A, Watanabe K, Iwamoto S, Kawai K, Kato M, Takahashi Y, Yamagata T. Two cases of DYNC1H1 mutations with intractable epilepsy. Brain Dev. 2021, Sep, 43(8): 857-862, doi:10.1016/j.braindev.2021.05.005.
1.Yukitoshi Takahashi, Autoimmune-associated epilepsy in childhood, Sino Japan Summit, 2022/3/24, China WEB, 海外, 口頭
国外 / 口頭
2.Yukitoshi Takahashi, Autoimmune-associated epilepsy & perampanel, China-Japan Pediatric Epilepsy Salon, 2021/10/13, China WEB, 海外, 口頭
3.Silvia Kalantari, Norah Alsaleh, Ghada M.H. Abdel-Salam, Fowzan Alkuraya, Mitsuhiro Kato, Naomichi Matsumoto; Satoko Miyatake; Lucas Fares-Taie, Caleb Bupp, Marcello Niceta, Bill Dobyns, Isabel Filges. Expanding the KIF4A-associated phenotype. European Human Genetics Conference Virtual Conference: Web 2021年8月28-31日, 海外, 口頭
4.Akihiko Kondo, Naotaka Usui, Naoki Ichikawa, Takayasu Tottori, Yukitoshi Takahashi, Strategies for additional resection after failed resective epilepsy surgery, the 13th Asian & Oceanian Epilepsy Congress (AOEC), 10-13 June, 2021, Virtual Congress, 国内, 口頭
国内 / 口頭
5.Naoki Ichikawa, Naotaka Usui, Akihiko Kondo, Takayasu Tottori, Yukitoshi Takahashi, Resective surgery for MRI nonlesional temporal lobe epilepsy without intracranial EEG, the 13th Asian & Oceanian Epilepsy Congress (AOEC), 10-13 June, 2021, Virtual Congres, 国内, 口頭
6.Inoue Y. EEG in Epilepsy. ASEPA workshop, Practical Use of EEG. AOEC 2021, Fukuoka (Web), 2021.6.10, 国内, 口頭
7.Inoue Y. Exhibition "Art around epilepsy" at annual meeting of the Japan Epilepsy Society. AOEC 2021, Fukuoka (Web), 2021.6.13, 国内, 口頭
8.Tabata K, Ishiyama A, Sugai K, Iwasaki M, Sumitomo N, Takeshita E, Shimizu-Motohashi Y, Saito Y, Komaki H, Nakagawa E, Sasaki M. A predictor for developmental and epileptic postsurgery prognosis in patients with hemimegalencephaly; A pre- and postsurgery study with N20 at non-HME side of median nerve short latency somatosensory evoked potentials. 13th Asian & Oceania Epilepsy Congress (AOEC) 第13回アジアオセアニアてんかん学会. WEB形式, June 10-13, 2021, 国内, 口頭
9.Ikegaya N, Iwasaki M, Kaneko Y, Kimura Y, Iijima K, Takayama Y, Yamamoto T, Sumitomo N, Saito T, Nakagawa E, Sasaki M. Neuropsychological and neurological sequelae after pediatric insular epilepsy surgery. 13th Asian & Oceania Epilepsy Congress (AOEC) 第13回アジアオセアニアてんかん学会. WEB形式, June 10-13, 2021, 国内, 口頭
10.Watanabe S, Nakagawa E, Saito T, Iwasaki M. The analysis of suppression-burst pattern in hemimegalencephaly patients who underwent hemispherotomy. 13th Asian & Oceania Epilepsy Congress (AOEC) 第13回アジアオセアニアてんかん学会. WEB形式, June 10-13, 2021, 国内, 口頭
11.Nakagawa E, Yamamoto H. Effect of methylphenidate and atomoxetine on electroencephalogram sleep studies in children with attention deficit hyperactivity disorder. 13th Asian & Oceania Epilepsy Congress (AOEC) 第13回アジアオセアニアてんかん学会. WEB形式, June 10-13, 2021, 国内, 口頭
12.Shiraishi H. Clinical features and semiology of different seizure types; why it matters? --Focal versus generalized seizures in children--. The 13th Asian & Oceanian Epilepsy Congress. June 13, 2021 (Fukuoka, Japan) , 国内, 口頭
13.Shiraishi H. The Value of Sodium Channel Blockers for IGE with GTCS. The 13th Asian & Oceanian Epilepsy Congress. June 11, 2021 (Fukuoka, Japan) , 国内, 口頭
14.Nakagawa E, Fukumura S, T. Language ominance in Children with epilepsy using near-infrared spectroscopy. 34th International Epilepsy Congress, Virtual Congress, 28 August-1 September, 2021, 海外, 口頭
15.Sugai K, Otsuki T, Saito T, Nakagawa E, Sasaki M, Iwasaki M, Takumi I. Outcome of medical treatment of postsurgical residual or relapsing seizures. 75th American Epilepsy Society Annual Meeting. WEB形式, Dec 3-7, 2021, 海外, 口頭
16.Ueda R, Iwasaki M, Kita Y, Takeichi H, Saito T, Nakagawa E, Sugai K, Okada T, Sasaki M.Improvement of brain function after surgery in infants with posterior quadrant cortical dysplasia. 75th American Epilepsy Society Annual Meeting. WEB形式, Dec 3-7, 2021, 海外, 口頭
17.Watanabe S, Nakagawa E, Saito T, Iwasaki M. A clinical report on the pathogenesis of suppression-burst by analyzing EEG from hemimegalencephaly patients who underwent hemispherotomy. The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases. WEB形式, Dec 14-16, 2021, 海外, 口頭
18.Sugai K, Otsuki T, Saito T, Nakagawa E, Sasaki M, Iwasaki M, Takumi I. Outcome of medical treatment of postsurgical residual or relapsing seizures. 75th American Epilepsy Society Annual Meeting (AES), Dec 3-7, 2021, 海外, 口頭
19.Ueda R, Iwasaki M, Kita Y, Takeichi H, Saito T, Nakagawa E, Sugai K, Okada T, Sasaki M.Improvement of brain function after surgery in infants with posterior quadrant cortical dysplasia. 75th American Epilepsy Society Annual Meeting (AES), Dec 3-7, 2021, 海外, 口頭
20.Watanabe S, Nakagawa E, Saito T, Iwasaki M. A clinical report on the pathogenesis of suppression-burst by analyzing EEG from hemimegalencephaly patients who underwent hemispherotomy. The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases., Dec 14-16, 2021, 海外, 口頭
1.加藤光広：希少てんかんに対する前向きコホートレジストリを対照群とする医師主導治験の成果と課題．6NC連携によるレジストリデータの活用基盤の構築事業 第3回レジストリフォーラム：新宿 online 2022年3月25日、国内
国内
2.限局性皮質異形成II型のてんかん発作に対するシロリムスの有効性と安全性．加藤光広、嘉田晃子、白石秀明、遠山潤、中川栄二、高橋幸利、秋山倫之、柿田明美、三宅紀子、藤田京志、齋藤明子、井上有史．第２回シロリムス新作用研究会：Online 2021年10月23日、国内
更新日：2023-04-12
